Antibody–drug nanoparticle induces synergistic treatment efficacies in HER2 positive breast cancer cells

Antibody–drug nanoparticle induces synergistic treatment efficacies in HER2 positive breast cancer cells

Abstract Chemotherapeutic drugs suffer from non-specific binding, undesired toxicity, and poor blood circulation which contribute to poor therapeutic efficacy. In this study, antibody–drug nanoparticles (ADNs) are engineered by synthesizing pure anti-cancer drug nanorods (NRs) in the core of nanopar...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Muhammad Raisul Abedin, Kaitlyne Powers, Rachel Aiardo, Dibbya Barua, Sutapa Barua
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/f71113ad9cc246b795e2a4ade2f68097
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares